10K downloads for #GNin10! 🥳 📈
Congratulations to our hosts @kdjhaveri.bsky.social & Dr. Koyal Jain for their incredible work & dedication to glomerular disease education. 🧬
🎧 Listen here: gninten.transistor.fm
👀 Stay tuned: Special #NephMadness episodes coming early March! 🏀 #NephTwitter #ISGD
A blue and purple promotional image for the "GN in Ten" podcast, featuring the International Society of Glomerular Disease logo. The text reads "Board Review Bonus #4: ANCA Vasculitis," and lists hosts Dr. Koyal Jain and Dr. Kenar Jhaveri. A stylized stopwatch icon is in the corner against a background of microscopic cellular structures.
🚨New GN in 10: Everything you need to know about ANCA Vasculitis🎙️
Join @kdjhaveri.bsky.social & Dr. Koyal Jain for a high-yield Board Review session covering all the basics and recent advances: share.transistor.fm/s/8be7fb84
#NephTwitter #MedEd #Vasculitis #BoardPrep @tobias-b-huber.bsky.social
The January issue of Kidney News is now online! Topics this month include:
⦁ A special section on Kidney Watch 2026, top areas to watch this year in nephrology
⦁ The ASN President's Update and new strategic plan
Explore the issue: kidney.pub/KN1801-01 #ASNKidneyNews Kenar Jhaveri, MD
Call for Applications: Submit your application for the Kidney News Editor-in-Chief position by February 2, 2026. Read the full call for applications: kidney.pub/KN-EIC #ASNKidneyNews Kenar Jhaveri, MD
Call for Applications: Submit your application for the Kidney News Editor-in-Chief position by February 2, 2026. Read the full call for applications: kidney.pub/KN-EIC #ASNKidneyNews @kdjhaveri.bsky.social
I didn’t know JNO stood for Jama network open. I thought it was Journal of Neuro Oncology
What study is JNO. ?
CDK4/6 in especially have a lot of pseudoAKI effect , AIN is totally idiosyncratic.
The subdistribution hazard ratios for progressive kidney dysfunction are shown for each drug group compared with their respective propensity score–matched cohort. The blue dots represent the hazard ratio and 95% CIs. Due to wide confidence intervals, MET inhibitors results reported in the text and not displayed here. MET inhibitors are included in overall treated group. Model is adjusted for hypertension, diabetes, ischemic heart disease, congestive heart failure, chronic obstructive pulmonary disease, cirrhosis, age, sex, race, body mass index, and eGFR before drug start. ALK indicates anaplastic lymphoma kinase; BRAF, B-Raf proto-oncogene, serine/threonine kinase; CDK4/6, cyclin dependent kinase 4 or 6; EGFR, endothelial growth factor receptor; ERBB2, human epidermal growth factor receptor 2; PARP, poly(adenosine diphosphate-ribose) polymerase; VEGFR, vascular endothelial growth factor receptor.
large cohort study of
CDK 4/6
BRAF
EGFR
VEGF
and other cancer treatments
#OncoNephrology #NephSky #KidneyWk
jamanetwork.com/journals/jam... from Shuchi Anand et al from @stanfordmedicine.bsky.social
www.kireports.org/article/S246... Critically Important Cancer Outcomes to Report in Kidney Transplant Trials
GN chat tomorrow
You are invited to a Zoom meeting.
When: Oct 28, 2025 08:00 AM Eastern Time (US and Canada)
Register in advance for this meeting:
northwell.zoom.us/meeting/regi...
After registering, you will receive a confirmation email containing information about joining the meeting.
Next #GN chat in a few days. Topic is Membranous Mysteries....
@hofstrakidney.bsky.social
When: Oct 28, 2025 08:00 AM Eastern Time (US and Canada)
northwell.zoom.us/meeting/regi...
After registering, you will receive a confirmation email containing information about joining the meeting.
Detective Nephron, renowned for his analytic skills, trains physician-detectives in the diagnosis and treatment of kidney diseases. Mac, a budding nephrologist, plans to present a new case to the master consultant. Can you solve it? #ASNKidneyNews kidney.pub/KN1710-06
@kdjhaveri.bsky.social
Congrats to all the awardees for the ANIO ASN Kidney Week Dinner and Awards 2025 an-io.com/2025/09/27/a...
What a fantastic evening at the #GlomConHawaii reception! Thank you to everyone who joined us🥰
It’s a privilege to be part of such an exceptional community. The future of nephrology is bright. @glomcon.org
What a great start to the WIN leadership conference! Great speakers and insights into career development, mentorship and work-life balance #womeninnephrology
@malasachdeva @DMalieckal @kdjhaveri.bsky.social @jiahweing @NicholasSusanne @purvasharma821 @GarovicVesna @HollyMarieMD @nicoleali
splash slide
Tomorrow!
We will have the @kdjhaveri.bsky.social from @hofstrakidney.bsky.social at the @uottawa.ca @ottawahospital.on.ca #NephGR
One more to start the WIN conference- Still time to register here @hofstrakidney.bsky.social @northwellhealth.bsky.social www.eventbrite.com/e/2025-women...
Returning after summer break on Sept 16
Our topic this time will be "IgAN Madness"
When: Sep 16, 2025 08:00 AM Eastern Time (US and Canada)
Register in advance for this meeting northwell.zoom.us/meeting/regi...
The final call is here. Submissions for Late-Breaking Clinical Trials close tomorrow, September 9, at 2:00 p.m. EDT. Submit Phase 2, 3, or 4 randomized clinical trials in AKI, CKD, diabetes, dialysis, transplantation, and more. Submit your research today: asn.kdny.info/KiXZ50WT7jL
The September issue of Kidney News is online! Topics include:
- Advancing AI applications for kidney diseases
- What the "One Big Beautiful Bill Act" means for kidney care + coverage
- Insights on IgA nephropathy
Explore the issue: kidney.pub/KN1709-01 #ASNKidneyNews
@kdjhaveri.bsky.social
The WIN conference agenda
Come witness the Women In Nephrology Leadership Conference @northwellhealth.bsky.social @hofstrau.bsky.social www.eventbrite.com/e/2025-women...
If you are a nephrology or kidney disease or renal professional or interested in the field - make sure you have liked/followed/pinned the nephrology feed
bsky.app/profile/did:...
Thanks again to @richardferro.xyz for creating & updating this! It’s a one-stop shop for nephrology needs
#NephSky
The Galdi Fellowship(GN-Onconephrology) @hofstrakidney.bsky.social
